[HTML][HTML] Nanoparticles for cancer therapy: current progress and challenges

S Gavas, S Quazi, TM Karpiński - Nanoscale research letters, 2021 - Springer
Cancer is one of the leading causes of death and morbidity with a complex pathophysiology.
Traditional cancer therapies include chemotherapy, radiation therapy, targeted therapy, and …

[HTML][HTML] Polymeric nanoparticles: production, characterization, toxicology and ecotoxicology

A Zielińska, F Carreiró, AM Oliveira, A Neves, B Pires… - Molecules, 2020 - mdpi.com
Polymeric nanoparticles (NPs) are particles within the size range from 1 to 1000 nm and can
be loaded with active compounds entrapped within or surface-adsorbed onto the polymeric …

[HTML][HTML] Lipid nanoparticles as carriers for bioactive delivery

N Dhiman, R Awasthi, B Sharma, H Kharkwal… - Frontiers in …, 2021 - frontiersin.org
Nanotechnology has made a great impact on the pharmaceutical, biotechnology, food, and
cosmetics industries. More than 40% of the approved drugs are lipophilic and have poor …

[HTML][HTML] Advances in nanoparticles-based approaches in cancer theranostics

MA Raheem, MA Rahim, I Gul, X Zhong, C Xiao… - OpenNano, 2023 - Elsevier
In recent years, the incidence and mortality rate of cancer is raising worldwide. Traditional
approaches for cancer patient management including surgery, chemotherapy, radiotherapy …

Polymers in topical delivery of anti-psoriatic medications and other topical agents in overcoming the barriers of conventional treatment strategies

K Yadav, A Soni, D Singh, MR Singh - Progress in Biomaterials, 2021 - Springer
In recent decades, topical treatments to dermal disorders have shown ineffectiveness in
delivering the medication at a particular location without a suitable drug carrier. Psoriasis …

[HTML][HTML] Concept for a unidirectional release mucoadhesive buccal tablet for oral delivery of antidiabetic peptide drugs such as insulin, glucagon-like peptide 1 (GLP-1 …

A Pratap-Singh, Y Guo, A Baldelli, A Singh - Pharmaceutics, 2023 - mdpi.com
Injectable peptides such as insulin, glucagon-like peptide 1 (GLP-1), and their agonists are
being increasingly used for the treatment of diabetes. Currently, the most common route of …

[HTML][HTML] Designing of SiO2 mesoporous nanoparticles loaded with mometasone furoate for potential nasal drug delivery: Ex vivo evaluation and determination of pro …

Y Mehmood, H Shahid, K Barkat… - Frontiers in Cell and …, 2023 - frontiersin.org
The main objective of the current research work was to synthesize mesoporous silica
nanoparticles for controlled delivery of mometasone furoate for potential nasal delivery. The …

Application of stimuli responsive nanocomposites in drug delivery and theranostics to counter cancer proliferation and drug resistance

N Khanna, T Chatterji, S Singh, S Pandey - Journal of Drug Delivery …, 2023 - Elsevier
Ingenious nanomedical researches have ameliorated outcomes in cancer theranostics.
Though limitations like non specific distribution generating low signal to noise ratio in …

Advances in kidney-targeted drug delivery systems

Z Chen, H Peng, C Zhang - International Journal of Pharmaceutics, 2020 - Elsevier
The management and treatment of kidney diseases currently have caused a huge global
burden. Although the application of nanotechnology for the therapy of kidney diseases is still …

[HTML][HTML] Nano biomaterials based strategies for enhanced brain targeting in the treatment of neurodegenerative diseases: an up-to-date perspective

DE Nayab, F Din, H Ali, WA Kausar, S Urooj… - Journal of …, 2023 - Springer
Neurons and their connecting axons gradually degenerate in neurodegenerative diseases
(NDs), leading to dysfunctionality of the neuronal cells and eventually their death. Drug …